A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

This study has been terminated.
(Diakron Pharmaceuticals couldn't fulfill the financial responsibility of the study)
Sponsor:
Collaborators:
Drug Research Unit Ghent, Ghent, Belgium
Kinesis Pharma BV, Breda, the Netherlands
Information provided by (Responsible Party):
Diakron Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01647620
First received: July 19, 2012
Last updated: February 23, 2015
Last verified: July 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)